COMPOSITIONS AND METHODS FOR ADDRESSING VISION IMPAIRMENT
The present disclosure relates to compositions for improving vision in a patient and methods of administering a composition to a patient, particularly in the form of a dietary supplement, which addresses vision impairment and promotes the health of a patient experiencing problems associated with deteriorated eyesight, including macular degeneration. The present disclosure also relates to methods for formulating the composition described herein.
1 . A method of treating a patient experiencing vision impairment or degeneration, comprising:
administering to the patient a composition comprising:
between about 500 IU and about 50,000 IU of Vitamin A;
between about 10 mg and about 2,000 mg of Vitamin C;
between about 10 mg and about 1,000 mg of Vitamin E;
between about 1 mg and about 50 mg of Zinc;
between about 10 mg and about 1,000 mg of Black Currant 25% Extract;
between about 2 mg and about 60 mg of Saffron EX 5C;
between about 1 mg and about 100 mg of Lutein; and
between about 0.2 mg and about 10 mg of Zeaxanthin.
2 . The method of claim 1 , wherein the vision impairment or degeneration comprises one or more of blurry vision, dry eyes, presbyopia, macular edema, cataracts, glaucoma, macular degeneration and temporal arteritis.
3 . The method of claim 1 , wherein the composition is administered to the patient in the form of a dietary supplement.
4 . The method of claim 1 , wherein the composition is administered to the patient in the form of a capsule or tablet.
5 . The method of claim 1 , wherein the Vitamin A is in the form of retinyl palmitate.
6 . The method of claim 1 , wherein the Vitamin C is in the form of ascorbic acid.
7 . The method of claim 1 , wherein the Vitamin E is in the form of mixed tocopherols.
8 . The method of claim 1 , wherein the Zinc is in the form of Zinc Glycinate.
9 . The method of claim 1 , wherein the composition administered to the patient further comprises a palatability agent selected from one or more of a plant oil, plant hydrolysates, yeast, yeast hydrolysates, and combinations thereof.
10 . The method of claim 1 , wherein the composition administered to the patient does not include milk, casein, gluten, wheat, eggs, peanuts, tree nuts, dairy, corn, soybeans, sugar and fish/shellfish.
11 . A method of treating the vision of a patient exhibiting impairment or degeneration relating to the same, wherein the method comprises administering to the patient a composition consisting essentially of:
about 10,000 IU of Vitamin A;
about 100 mg of Vitamin C;
about 100 mg of Vitamin E;
about 10 mg of Zinc;
about 100 mg of Black Currant 25% Extract;
about 20 mg of Saffron EX 5C;
about 10 mg of Lutein; and
about 2 mg of Zeaxanthin.
12 . The method of claim 11 , wherein the Vitamin A is in the form of retinyl palmitate.
13 . The method of claim 11 , wherein the Vitamin C is in the form of ascorbic acid.
14 . The method of claim 11 , wherein the Vitamin E is in the form of mixed tocopherols.
15 . The method of claim 11 , wherein the Zinc is in the form of Zinc Glycinate.
16 . The method of claim 11 , wherein the composition administered to the patient is devoid of the following: milk, casein, gluten, wheat, eggs, peanuts, tree nuts, dairy, corn, soybeans, sugar and fish/shellfish.
17 . The method of claim 11 , wherein the composition is administered to the patient in the form of a dietary supplement.
18 . The method of claim 11 , wherein the composition is administered to the patient in the form of a capsule, and between one and four capsules are administered to the patient daily.
19 . The method of claim 11 , wherein the composition is administered orally in the form of a tablet.
20 . The method of claim 11 , wherein the composition further comprises a palatability agent, the palatability agent comprising at least one of a plant oil, plant hydrolysates, yeast, and yeast hydrolysates, and combinations thereof.